Amany Mansour-Awad, RPh, MBA
PRESIDENT AND FOUNDER
Amany has over 20 years of experience working in pharmaceutical manufacturing, pharmaceutical regulatory affairs, hospital/clinical pharmacies, and specialty pharmacies. As such, Amany has extensive operational and quality assurance expertise in various pharmaceutical practice settings.
Early in her career, Amany’s entry into the pharmaceutical world was as an international GMP consultant. In this position, Amany worked in Tokyo, Japan for over 3 years, specializing in pharmaceutical engineering. After she returned to the US, Amany practiced as a Business Development Manager and Pharmaceuticals Strategy Consultant to midsize pharmaceutical engineering/validation firms.
After successfully building and monetizing her consulting and corresponding pharmaceutical validation software technologies (for which Amany was granted a US patent), Amany turned her professional interests to clinical pharmacy settings and worked at some of the region’s leading healthcare institutions including Jefferson Neuroscience Hospital and the Health System at the University of Pennsylvania. It is with these experiences that Amany rediscovered the substantial benefits of compounded specialty drugs as an integral part of a comprehensive healthcare management plan.
Amany combined her new-found interest in compounding with her honed business acumen to open Chemistry Rx in 2013. Amany wanted to develop a unique compounding pharmacy that works intimately with prescribers to design highly customized compounds for patients as part of their overall healthcare management regimen. Since the opening of Chemistry Rx, Amany has stayed true to her goal and provided hundreds of patients across the region with novel compounded treatment options.
Amany is a proud graduate of the Philadelphia College of Pharmacy and Sciences (now the University of Sciences, Philadelphia) with a BS in Pharmacy and received an MBA with distinction from the Fox School of Business, Temple University.
Lars Brichta, PharmD, PhD
COO AND DIRECTOR OF CLINICAL AND SCIENTIFIC AFFAIRS
Lars graduated from pharmacy school at the Martin Luther University in Halle, Germany and received his PhD in Neurogenetics from the Universities of Bonn and Cologne. Before moving to the United States, he worked in hospital and retail pharmacies in Germany. He also gained experience in the Research and Development department of Novartis Pharma AG in Basel, Switzerland, where he studied the impact of pharmaceutical excipients on the pharmacokinetic behavior of antihypertensive drugs.
Lars is an expert in the field of neurologic and neurodegenerative disorders. After training at the National Institutes of Health, he studied the degeneration of motor neurons in spinal muscular atrophy (SMA), a rare genetic disease that mainly affects children, and discovered the therapeutic potential of histone deacetylase inhibitors. From 2006 until 2015, he carried out research focusing on the molecular underpinnings of dopaminergic neuron degeneration in Parkinson’s disease at the Rockefeller University in New York in the laboratory of Nobel Laureate Paul Greengard and identified novel proteins involved in the loss of these neurons. Lars published a number of articles in several renowned scientific journals.
At Chemistry Rx, Lars provides consultations on novel and specialty medications to practitioners and patients and supports practitioners in obtaining prior authorizations. He specializes in the development of novel formulations for various disorders with a focus on dermatologic conditions in children and adults as well as mitochondrial, metabolic and other rare disorders. He has also contributed to multiple clinical trials and been mentioned a several published papers.
His latest contribution was for Topical Janus kinase Inhibitors for Pediatric Alopecia: External link to article
Robert Desantis, PharmD, RPh
DIRECTOR OF OPERATIONS
Robert Desantis graduated with honors from the Philadelphia College of Pharmacy in 2014 with a Bachelor of Science in Pharmaceutical and Healthcare Studies and a Doctorate in Pharmacy. He oversees all compounding procedures and the day-to-day workflow at Chemistry Rx and precepts pharmacy interns. Robert is also responsible for the pharmacy’s safety policies and initiatives, maintains and updates our standard operating procedures and supervises the pharmacy’s technicians.
Vivi Jung, PharmD, RPh
PHARMACIST IN CHARGE AND DIRECTOR OF MARKETING
Vivi Jung graduated with honors from the Philadelphia College of Pharmacy in 2014 with a Bachelor of Science in Pharmaceutical and Healthcare Studies and a Doctorate in Pharmacy. As the Pharmacist in Charge, she handles all licensing, accreditation and credentialing for the pharmacy to maintain the highest standards for compounding and patient care. Vivi is responsible for the general marketing of the pharmacy as well as social media presence. She also provides other healthcare professionals with clinical information and support for prior authorizations. Vivi precepts pharmacy students and interns.
Krupesh Patel, BS – Pharmacology
DIRECTOR OF QUALITY ASSURANCE
Krupesh Patel graduated from the University of Sciences, Philadelphia with a Bachelor of Science in Pharmacology in 2015. He started working at Chemistry Rx in 2014 and received extensive training at PCCA. Since 2015, Krupesh is the lead compounding technician. He enjoys working with our pharmacists to formulate novel medications. Krupesh is also in charge of the pharmacy’s employee safety initiatives and takes care of IT and other technical operation issues that may arise.
829 Spruce Street, Suite 100
Philadelphia, PA 19107
F: 267- 861-0862
A prescription from a licensed practitioner is required for compounded medications.
The content and photographs on this website are copyrighted or licensed material and may not be downloaded for other than personal use. Retransmission, republication, reproduction or any other use of the content or photographs is prohibited.